ATE325817T1 - Verfahren zur herstellung von immunoglobulin a in milch - Google Patents

Verfahren zur herstellung von immunoglobulin a in milch

Info

Publication number
ATE325817T1
ATE325817T1 AT98929914T AT98929914T ATE325817T1 AT E325817 T1 ATE325817 T1 AT E325817T1 AT 98929914 T AT98929914 T AT 98929914T AT 98929914 T AT98929914 T AT 98929914T AT E325817 T1 ATE325817 T1 AT E325817T1
Authority
AT
Austria
Prior art keywords
milk
producing
producing immunoglobulin
preparations
useful
Prior art date
Application number
AT98929914T
Other languages
English (en)
Inventor
Alison Joy Hodgkinson
Steven Charles Hodgkinson
Original Assignee
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd filed Critical Agres Ltd
Application granted granted Critical
Publication of ATE325817T1 publication Critical patent/ATE325817T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT98929914T 1997-05-29 1998-05-29 Verfahren zur herstellung von immunoglobulin a in milch ATE325817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ31495997 1997-05-29

Publications (1)

Publication Number Publication Date
ATE325817T1 true ATE325817T1 (de) 2006-06-15

Family

ID=19926267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929914T ATE325817T1 (de) 1997-05-29 1998-05-29 Verfahren zur herstellung von immunoglobulin a in milch

Country Status (9)

Country Link
US (3) US6616927B2 (de)
EP (1) EP0990001B1 (de)
JP (1) JP2002501526A (de)
AT (1) ATE325817T1 (de)
AU (1) AU738888B2 (de)
BR (1) BR9809186A (de)
CA (1) CA2291487A1 (de)
DE (1) DE69834490T2 (de)
WO (1) WO1998054226A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ285883B6 (cs) * 1998-01-19 1999-11-17 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid telat
US20020009429A1 (en) * 1999-01-29 2002-01-24 Galagen, Inc. Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
US6974573B2 (en) * 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
DE60025945T2 (de) * 1999-11-01 2006-09-28 Mucovax Holding B.V. Herstellung von antikörpern in mammarsekreten von zuchttieren
WO2002072142A2 (en) * 2001-03-12 2002-09-19 Rijksuniversiteit Groningen Modulation of a balance between the gut mucosal immune system and the intestinal microflora
AU2002367161A1 (en) * 2001-12-24 2003-07-15 Fonterra Co-Operative Group Limited Immunoglobulin composition
CA2540541C (en) 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
FI116904B (fi) * 2003-10-21 2006-03-31 Suomen Rehu Oy Menetelmä maidon koostumuksen muuttamiseksi ja maidon käyttö
WO2005041992A2 (en) * 2003-10-22 2005-05-12 Harry Leneau Colostrum compositions and methods
FR2861306B1 (fr) * 2003-10-28 2008-07-04 Vivafeed Utilisation du shiitake pour augmenter le taux d'immunoglobulines laitieres
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
NZ530709A (en) * 2004-01-21 2006-07-28 Agres Ltd Improved IGA production method
EP1835915A4 (de) * 2004-12-30 2010-02-24 Coley Pharm Group Inc Formulierungen und verfahren zur modifizierung der immunantwort
EP1844201B1 (de) 2005-02-04 2016-08-24 3M Innovative Properties Company Wässrige gelformulierungen mit immunreaktionsmodifikatoren
WO2006119560A1 (en) * 2005-05-10 2006-11-16 Murray Goulburn Co-Operative Co Limited Immunoglobulin fraction and process therefor
AU2006304886B2 (en) * 2005-10-21 2012-04-12 Genzyme Corporation Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
EP2222192A1 (de) * 2007-12-11 2010-09-01 Nestec S.A. Vorbeugung und behandlung von otitis media mittels iga-angereicherter milch
EP2138187A1 (de) * 2008-06-24 2009-12-30 Nestec S.A. Probiotika, sekretorische IgA und Infektion
WO2010050829A1 (en) * 2008-10-31 2010-05-06 Vialactia Biosciences (Nz) Limited Marker assisted selection of a mammalian subject for desired immunoglobulin phenotype
KR102037885B1 (ko) 2010-11-23 2019-10-30 팬더릭스 인코포레이티드 광범위한, 미확인 또는 혼합된 임상적 적용에서 치료용 조성물들 및 방법들
MX2015010427A (es) 2013-02-13 2016-03-17 Lab Francais Du Fractionnement Anticuerpos anti-tnf-alfa altamente galactosilados y sus usos.
EP2956003A2 (de) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteine mit modifizierter glykosylierung und verfahren zur herstellung davon

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4229342A (en) 1977-05-18 1980-10-21 Rhone-Poulenc Industries Process for extracting proteins from milk using silica and anion exchange resins
FR2520235A1 (fr) 1982-01-27 1983-07-29 Bel Fromageries Procede de separation d'immunoglobulines a partir de colostrum
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
DE3432718C1 (de) 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
US5066491A (en) 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
FR2584727B1 (fr) 1985-07-11 1988-06-17 Roussel Uclaf Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
GB8729031D0 (en) 1987-12-11 1988-01-27 Express Foods Group Ltd Isolation of immunoglobulin rich fraction from whey
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
US5258178A (en) 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
IE76730B1 (en) 1990-07-30 1997-11-05 Abbott Laboraties Method and product for the treatment of gastric disease
NZ239466A (en) 1990-08-17 1993-12-23 Us Agriculture Desalted colostrum: spray dried product from retentate of
US5418137A (en) * 1991-09-26 1995-05-23 Paravax, Inc. Flea membrane binding site proteins as screening tools
US5155213A (en) * 1991-10-28 1992-10-13 Eloy Padron Method for isolating IgAs in the feces
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
AU1458497A (en) 1996-01-31 1997-08-22 John Stephen Ayers Production of an immunoglobulin enriched fraction from whey protein solutions

Also Published As

Publication number Publication date
US20030074676A1 (en) 2003-04-17
EP0990001A4 (de) 2004-08-25
US20020076410A1 (en) 2002-06-20
EP0990001B1 (de) 2006-05-10
JP2002501526A (ja) 2002-01-15
AU7942098A (en) 1998-12-30
US20030103989A1 (en) 2003-06-05
EP0990001A1 (de) 2000-04-05
BR9809186A (pt) 2000-08-01
WO1998054226A1 (en) 1998-12-03
DE69834490T2 (de) 2007-03-01
US6616927B2 (en) 2003-09-09
DE69834490D1 (de) 2006-06-14
AU738888B2 (en) 2001-09-27
CA2291487A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
ATE325817T1 (de) Verfahren zur herstellung von immunoglobulin a in milch
ATE238695T1 (de) Mayonnaiseähnliches produkt und verfahren zur herstellung desselben
EP1262192A3 (de) Zusammensetzungen und Methoden welche der humanen gastrointestinalen Gesundheit dienen
DE69626833D1 (de) Ernährungsergänzungsgetränk und verfahren zur herstellung desselben
DE69709195T2 (de) Delactosierte Milch und Milchpulver, diese enthaltende Nahrungsmittel und die entsprechendes Verfahren
ATE362707T1 (de) Verfahren zur herstellung von milchpulver und konzentrierten milchprodukten
ITBO950521A0 (it) Apparecchiatura e metodo per la formazione di gruppi ordinati di prodotti da alimentare a passo.
DE69518308D1 (de) Produkt und verfahren zur herstellung von sukrosefreien milchschokoladen
ZA939295B (en) Milk product
DE69329923D1 (de) Molkenprotein und molkenproteinhydrolysate, und verfahren zur herstellung
ATE290003T1 (de) Verfahren zur herstellung von pyrazolo-(4,3- d)pyrimidin-7-ones und zwischenprodukte davon
ATE190050T1 (de) Verfahren zur herstellung von 2-acetyl-1-pyrrolin in verkapselter form, zwischenprodukte und endprodukt
DE69427442D1 (de) Fermentierte milch und verfahren zur herstellung
DE3782539D1 (de) Verfahren zur herstellung eines aromatisierungsmittels, und dieses mittel enthaltende nahrungsmittel.
DE69609893T2 (de) Verfahren zur Herstellung von mit Kalzium angereicherten Milchgetränken
DE69616513T2 (de) Verfahren zur herstellung von lagerstabilen milchprodukten
DE69623319T2 (de) Milchprodukt und verfahren zu dessen herstellung
DE69620589T2 (de) Gefrorenes konzentriertes Milchprodukt und Verfahren zu dessen Herstellung
DE59704808D1 (de) Verfahren zur herstellung von kolostralmilchprodukten sowie deren verwendung
DE69801007T2 (de) Auf käse und biskuit basierendes kompositnahrungsmittel und verfahren zu dessen herstellung
DE59208729D1 (de) Gekühlte, pasteurisierte, streichfähige Fleisch- oder Fischmousse sowie Verfahren zu ihrer Herstellung
ITVI910059A0 (it) Metodo per la pastorizzazione di prodotti alimentari e pastorizzatore atto a realizzare tale metodo
FI103089B1 (fi) Ternimaidon heraan perustuva ravintovalmiste ja menetelmä sen valmistamiseksi
DE59603909D1 (de) Verfahren zur Herstellung von Lebensmittelzubereitungen, insbesondere Fruchtzubereitungen
AT389427B (de) Verfahren zur herstellung haltbarer, dehydrierter molkereiprodukte, naemlich butter und kaese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties